NYSE News: NYSE 100, NYSE 250, and NYSE 400 investment news
NYSE market news from the New York Stock Exchange

Latest NYSE News:

  • Oil, solar sectors gain on record crude prices

  • Microsoft up 9.2 percent on quarterly results

  • New home sales numbers don’t help Wall Street

  • Dow loses over 130 points by midday

  • Merck profits up 62 percent in third quarter

  • Quarterly reports disappoint Wall Street

  • Wall Street lower on banking sector

  • Wall Street mixed to end session

  • Home builders decline on comments, news

  • Citigroup lower on quarterly report

  • NYSE news feed


    Recommended equities news sites

  • NYSE
  • NasDaq
  • Dow Jones
  • Finance & Money
  • Eurofirst News
  • Tokyo Market News
  • FTSE News
  •  

    December 4, 2006

    Nasdaq Composite adds 1.6 percent by noon

    Filed under: Administaff, Pfizer, Bank of New York, IBM, Mellon Financial, Station Casinos, Onyx Pharmaceuticals

    The New York equities markets were higher at midday on Monday, helped out by falling oil prices. The Dow Jones Industrial average was 0.5 percent higher to 12,256.78, while the Nasdaq Composite was up 1.3 percent to 2,444.20 and the S&P 500 had added 0.6 percent to 1,405.15. The small-cap Russell 2000 index was up 1.6 percent to 793.32, just below its all-time high.

    In the financial services sector, Bank of New York said it will purchase Mellon Financial for $16.5 billion, all in stock. If the deal is closed, it will create the largest financial assets service company, with control of around $16,000 billion. Bank of New York had added 11.1 percent on the news by the middle of the day to $39.41, while Mellon gained 4.4 percent to $42.27.

    Station Casinos added 18.7 percent to $82.02 and was up to $82.28 earlier in the day after it said it has received a bid from a group of investors headed by the chairman and chief executive of the company. The offer was said to be worth $4.7 billion.

    IBM was 1.6 percent higher to $92.73 on positive notice from the press over the weekend.

    The pharmaceuticals sector saw declines after Pfizer and Onyx Pharmaceuticals each received bad news about drugs in trials. Pfizer fell 11.8 percent to $24.58 after dropping as low as $23.52 on the announcement that it has abandoned development of its Torcetrapib, intended to treat high cholesterol, after patients in trials had a high incidence of deaths and cardiovascular events. Meanwhile, Onyx dropped 28.9 percent to $12.44 on the announcement that Nexavar, a drug for the treatment of kidney cancer, had not helped skin cancer patients in trials.





    Latest Equities News:

  • Wall Street ends lower despite rate cut

  • Asia-Pacific, Europe equities see declines

  • Hang Seng adds 10.72 percent on session

  • India’s Sensex drops 1,408 points on session

  • Australian markets drop for 9th straight day

  • Taiex gains on opposition win in parliamentary elections

  • Hang Seng drops nearly 400 points

  • Most Asia-Pacific markets drop on US recession worries

  • Tokyo declines on export worries

  • Asia-Pacific equities mixed on economic concerns

  • NYSE News copyright 2005 Central Consultants